|
|
|
|
Vol. 15, Issue 3, 990-1002, March 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Institut fuer Physiologische Chemie, Abteilung fuer Zellbiochemie, Universitaetsklinikum Bonn, 53115 Bonn, Germany;
Division of Cell Biology, German Cancer Research Center, 69120 Heidelberg, Germany; and
Department of Anatomy, Johannes Gutenberg-University, D-55128 Mainz, Germany
Submitted September 24, 2003;
Revised October 20, 2003;
Accepted October 31, 2003
Monitoring Editor: Richard Hynes
Dominant keratin mutations cause epidermolysis bullosa simplex by transforming keratin (K) filaments into aggregates. As a first step toward understanding the properties of mutant keratins in vivo, we stably transfected epithelial cells with an enhanced yellow fluorescent protein-tagged K14R125C mutant. K14R125C became localized as aggregates in the cell periphery and incorporated into perinuclear keratin filaments. Unexpectedly, keratin aggregates were in dynamic equilibrium with soluble subunits at a half-life time of <15 min, whereas filaments were extremely static. Therefore, this dominant-negative mutation acts by altering cytoskeletal dynamics and solubility. Unlike previously postulated, the dominance of mutations is limited and strictly depends on the ratio of mutant to wild-type protein. In support, K14R125C-specific RNA interference experiments resulted in a rapid disintegration of aggregates and restored normal filaments. Most importantly, live cell inhibitor studies revealed that the granules are transported from the cell periphery inwards in an actin-, but not microtubule-based manner. The peripheral granule zone may define a region in which keratin precursors are incorporated into existing filaments. Collectively, our data have uncovered the transient nature of keratin aggregates in cells and offer a rationale for the treatment of epidermolysis bullosa simplex by using short interfering RNAs.
Abbreviations used: EBS, epidermolysis bullosa simplex; EYFP, enhanced yellow fluorescent protein; IF, intermediate filament; K, keratin; MF, microfilament; MT, microtubule; mut, mutant; wt, wild type.
![]()
Online version of this article contains video and supplementary material for some figures. Online version is available at www.molbiolcell.org.
Corresponding author. E-mail address: t.magin{at}uni-bonn.de.
This article has been cited by other articles:
![]() |
S. Kim and P. A. Coulombe Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm Genes & Dev., July 1, 2007; 21(13): 1581 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Woll, R. Windoffer, and R. E. Leube p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells J. Cell Biol., June 21, 2007; 177(5): 795 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Long, V. Boczonadi, L. McInroy, M. Goldberg, and A. Maatta Periplakin-dependent re-organisation of keratin cytoskeleton and loss of collective migration in keratin-8-downregulated epithelial sheets J. Cell Sci., December 15, 2006; 119(24): 5147 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P HICKERSON, F. J. D SMITH, W. H IRWIN MCLEAN, M. LANDTHALER, R. E LEUBE, and R. L KASPAR SiRNA-Mediated Selective Inhibition of Mutant Keratin mRNAs Responsible for the Skin Disorder Pachyonychia Congenita Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Osmanagic-Myers, M. Gregor, G. Walko, G. Burgstaller, S. Reipert, and G. Wiche Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration J. Cell Biol., August 14, 2006; 174(4): 557 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Windoffer, A. Kolsch, S. Woll, and R. E. Leube Focal adhesions are hotspots for keratin filament precursor formation J. Cell Biol., May 8, 2006; 173(3): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishizawa, I. Izawa, A. Inoko, Y. Hayashi, K.-i. Nagata, T. Yokoyama, J. Usukura, and M. Inagaki Identification of trichoplein, a novel keratin filament-binding protein J. Cell Sci., March 1, 2005; 118(5): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Gu and P. A. Coulombe Defining the Properties of the Nonhelical Tail Domain in Type II Keratin 5: Insight from a Bullous Disease-causing Mutation Mol. Biol. Cell, March 1, 2005; 16(3): 1427 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Omary, P. A. Coulombe, and W.H. I. McLean Intermediate Filament Proteins and Their Associated Diseases N. Engl. J. Med., November 11, 2004; 351(20): 2087 - 2100. [Full Text] [PDF] |
||||